Tag: viral inactivation market value

  • $8.28 Billion Forecast for Viral Inactivation Market by 2029, Backed by Demand and Innovation

    $8.28 Billion Forecast for Viral Inactivation Market by 2029, Backed by Demand and Innovation

    Discover trends, market shifts, and competitive outlooks for the viral inactivation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    What Are the Key Milestones in the Viral Inactivation Market’s Growth Trajectory From 2025 To 2034?

    The market size for viral inactivation has seen substantial growth in recent times. It is projected to expand from $5.01 billion in 2024 to $5.48 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. The remarkable growth in the previous years can be linked to the rise in global air traffic, improved navigation skills, growth in commercial aviation, savings on airline expenses, enhanced flight security, and a decrease in pilot workload.

    The market size for viral inactivation is anticipated to experience expeditious growth in the upcoming years. It is projected to reach “$8.28 billion by 2029 with a compound annual growth rate (CAGR) of 10.9%. The surge during the projected period is due to factors such as the development of autonomous flights, innovative aircraft designs, strides towards eco-friendly aviation, urban air mobility (uam) and a heightened demand for aircraft. Key trends observed during the projected period encompass the integration of superior avionics, the introduction of artificial intelligence, advancements in the human-machine interface (hmi), refurbishing of existing aircraft and integration of the global navigation satellite system (gnss).

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

    What Are the Core Growth Drivers Propelling the Viral Inactivation Market Forward?

    The viral inactivation market is predicted to flourish due to the rising occurrences of different infectious diseases. These diseases, typically transmitted from person to person through tainted food and drink or pathogens like viruses, bacteria, fungi, and parasites, play into the necessity for viral inactivation. It is used extensively in disease-control efforts in humans to counteract viruses with the help of physical and chemical disinfectants, curbing the spread of highly infectious viral conditions. This concept accounts for the marked expansion of the viral inactivation market. To illustrate, the Centers for Disease Control and Prevention, a United States national public health institution, reported that tuberculosis cases grew from 8,320 in 2022 to 9,615 in 2023, a rise of 1,295 cases. The rate likewise went up from 2.5 per 100,000 people in 2022 to 2.9 in 2023. Thus, the mounting instances of assorted infectious diseases are boosting the growth of the viral inactivation market.

    What Segment Types Define the Viral Inactivation Market Structure?

    The viral inactivation market covered in this report is segmented –

    1) By Product: Kits And Reagents, Systems, Services

    2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

    3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

    4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

    Subsegments:

    1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

    2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

    3) By Services: Viral Testing Services, Validation Services, Consulting Services

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10401&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Viral Inactivation Market?

    North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Which Emerging Trends that Are Influencing theViral Inactivation Industry Evolution?

    The surge in the adoption of advanced technological methods is becoming a prominent trend in the viral inactivation market. Companies existing in this market are leveraging these sophisticated processes to maintain their market hold. For example, in March 2022, WuXi Advanced Therapies, a fully owned subsidiary of WuXi AppTec, a biopharmaceutical firm based in China, introduced the Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology. This state-of-the-art technology has facilitated the approval of new therapies by synchronously conducting all assay formulation, biosafety, viral clearance, product release, and testing tasks, in-house. This approach represents a newly invented way of producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) standard, eliminating the requirement for transfection.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

    What Is the Definition of the Viral Inactivation Market?

    Viral inactivation refers to the process of inactivation of viral contamination by exposing the bioprocess fluid to environments that denature the viral protein yet retain the active ingredient of the product. Viral inactivation is most commonly used in blood plasma processing and monoclonal antibody processing.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How is the Viral Inactivation Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the viral inactivation market grown over the years?

    The market size of viral inactivation has experienced substantial growth in the past few years. From 2024 to 2025, it is projected to increase from $5.01 billion to $5.48 billion, growing at a compound annual growth rate (CAGR) of 9.4%. The surge during the historic period can be traced back to the global increase in air traffic, advanced navigation abilities, expansion of commercial aviation, cost-effective airline operations, improved flight safety measures, and decrease in pilot workload.

    What Is the forecasted market size and growth rate for the viral inactivation market?

    The expansion of the viral inactivation market is projected to surge swiftly in the forthcoming years, reaching a value of “$8.28 billion in 2029, with a compound growth rate (CAGR) of 10.9%. This expected increase during the forecast period is credited to the development of independent flight technologies, innovative designs for future aircraft, sustainable aviation strategies, urban air mobility (UAM), and a rising demand for aircraft. Key trends during this forecast period include the incorporation of cutting-edge avionics, the deployment of artificial intelligence, advances in human-machine interface (HMI), modernization of existing aircraft, and the integration of the global navigation satellite system (GNSS).

    Get your viral inactivation market report here!

    https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

    What are the major factors driving growth in the viral inactivation market?

    The rise in different infectious diseases is anticipated to drive the expansion of the viral inactivation market. These diseases, which can spread from one person to another through contaminated food and drinks, and due to pathogens like viruses, bacteria, fungi, and parasites, necessitates the use of viral inactivation. This method, which effectively uses physical and chemical disinfectants to neutralize viruses, is crucial in human disease prevention programs, thereby contributing to the growth of the viral inactivation market. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, reported in March 2024 that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. The rate also went up from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Consequently, the rising occurrences of several infectious diseases are fueling the expansion of the viral inactivation market.

    What key areas define the segmentation of the global viral inactivation Market?

    The viral inactivation market covered in this report is segmented –

    1) By Product: Kits And Reagents, Systems, Services

    2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

    3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

    4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

    Subsegments:

    1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

    2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

    3) By Services: Viral Testing Services, Validation Services, Consulting Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

    What are the top market players propelling the growth of the viral inactivation industry?

    Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

    What are the key trends shaping the future of the viral inactivation market?

    A prevalent trend emerging in the viral inactivation market is the increasing implementation of cutting-edge technologies. Firms working in this sector are embracing top-tier tech processes to maintain market relevance. For example, WuXi Advanced Therapies, fully owned by WuXi AppTec (a China-based bioscience company), unveiled its Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology in March 2022. This revolutionary technology has simplified the approval of novel therapies by concomitantly executing assay formulation, biosafety, viral purification, product launch, and checks, all from within their premises. This procedure presents a groundbreaking technique for generating Good Manufacturing Practices (GMP) grade adeno-associated virus (AAV) without the requirement for transfection.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

    What regions are dominating the viral inactivation market growth?

    North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Healthcare E-Commerce Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report

    Healthcare Personal Protective Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

    Pharmacies and Healthcare Stores Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How is the Viral Inactivation Market Poised for Growth: Trends and Opportunities Through 2034

    How is the Viral Inactivation Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the viral inactivation market grown over the years?

    The market size of viral inactivation has experienced substantial growth in the past few years. From 2024 to 2025, it is projected to increase from $5.01 billion to $5.48 billion, growing at a compound annual growth rate (CAGR) of 9.4%. The surge during the historic period can be traced back to the global increase in air traffic, advanced navigation abilities, expansion of commercial aviation, cost-effective airline operations, improved flight safety measures, and decrease in pilot workload.

    What Is the forecasted market size and growth rate for the viral inactivation market?

    The expansion of the viral inactivation market is projected to surge swiftly in the forthcoming years, reaching a value of “$8.28 billion in 2029, with a compound growth rate (CAGR) of 10.9%. This expected increase during the forecast period is credited to the development of independent flight technologies, innovative designs for future aircraft, sustainable aviation strategies, urban air mobility (UAM), and a rising demand for aircraft. Key trends during this forecast period include the incorporation of cutting-edge avionics, the deployment of artificial intelligence, advances in human-machine interface (HMI), modernization of existing aircraft, and the integration of the global navigation satellite system (GNSS).

    Get your viral inactivation market report here!

    https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

    What are the major factors driving growth in the viral inactivation market?

    The rise in different infectious diseases is anticipated to drive the expansion of the viral inactivation market. These diseases, which can spread from one person to another through contaminated food and drinks, and due to pathogens like viruses, bacteria, fungi, and parasites, necessitates the use of viral inactivation. This method, which effectively uses physical and chemical disinfectants to neutralize viruses, is crucial in human disease prevention programs, thereby contributing to the growth of the viral inactivation market. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, reported in March 2024 that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. The rate also went up from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Consequently, the rising occurrences of several infectious diseases are fueling the expansion of the viral inactivation market.

    What key areas define the segmentation of the global viral inactivation Market?

    The viral inactivation market covered in this report is segmented –

    1) By Product: Kits And Reagents, Systems, Services

    2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

    3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

    4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

    Subsegments:

    1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes

    2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems

    3) By Services: Viral Testing Services, Validation Services, Consulting Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp

    What are the top market players propelling the growth of the viral inactivation industry?

    Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited

    What are the key trends shaping the future of the viral inactivation market?

    A prevalent trend emerging in the viral inactivation market is the increasing implementation of cutting-edge technologies. Firms working in this sector are embracing top-tier tech processes to maintain market relevance. For example, WuXi Advanced Therapies, fully owned by WuXi AppTec (a China-based bioscience company), unveiled its Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology in March 2022. This revolutionary technology has simplified the approval of novel therapies by concomitantly executing assay formulation, biosafety, viral purification, product launch, and checks, all from within their premises. This procedure presents a groundbreaking technique for generating Good Manufacturing Practices (GMP) grade adeno-associated virus (AAV) without the requirement for transfection.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401

    What regions are dominating the viral inactivation market growth?

    North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Healthcare E-Commerce Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report

    Healthcare Personal Protective Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

    Pharmacies and Healthcare Stores Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: